- Resources
Singulair 10mg Tab Merck
What is the concern about Singulair (montelukast)?
Singulair is a major drug in asthma treatment – it is important to review recent developments and put these findings in perspective of overall asthma care for individual patients.
Singulair (montelukast)
Singulair (manufactured and marketed by Merck and Co.) is a drug of the so-called anti-leukotriene class that is used for control of symptoms of asthma and allergic rhinitis (hay fever). It was initially approved by the U.S. Food and Drug...
More information on "Singulair 10mg Tab Merck"
From Our Experts
Singulair and the FDA: Are they keeping us safe?
Did you see the reports last week that Singulair was going to be investigated by the Food and Drug Administration for reports of a "casual... Read more »
Singulair and Asthma: Getting Scared Smart
My e-mail is buzzing. "Have you seen the news about Singulair? Are you worried?" The short answer is, "No, I'm not concerned at all." ... Read more »
FDA Investigating Singulair
The FDA has announced it is investigating a possible association between the use of Singulair and behavior/mood changes, suicidality... Read more »
Great News: Little Evidence That Taking Singulair Leads to Suicide
In March 2008, in a pre-emptive move, Merck announced that its allergy/asthma drug, Singulair, might cause some people to act on suicidal... Read more »
Type 2 Diabetes Has Its Very Own iPad+iPhone App: The Vree for...
The Vree for Diabetes 2.0 is a new program developed by Merck & Co., Inc. specifically focused on helping people with type 2 diabetes... Read more »
From Our Sources
Singulair may be better for overweight patients
Scientists report that the asthma pill montelukast (Singulair) may work better for patients who are overweight or obese than inhaled asthma... Read more »
FDA to review Singulair, Claritin combo med
The Food and Drug Administration is scheduled to review a new allergy medication for market approval. The med is a combination of the asthma drug... Read more »
FDA rejects Claritin, Singulair combo med
The U.S. Food and Drug Administration (FDA) has turned down an application for a combo allergy drug. The medication would have combined the allergy... Read more »
FDA investigates Singulair, suicide link
The U.S. Food and Drug Administration (FDA) is invesigating a possible link between the asthma drug Singulair and reports of mood changes and... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
